Texas § 442.053 REQUIREMENTS FOR DONATED PRESCRIPTION DRUGS.

Texas Statutes

§ 442.053 — REQUIREMENTS FOR DONATED PRESCRIPTION DRUGS.

Texas § 442.053

Code HSHealth and Safety Code

This text of Texas § 442.053 (REQUIREMENTS FOR DONATED PRESCRIPTION DRUGS.) is published on Counsel Stack Legal Research, covering Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Tex. Health and Safety Code Code Ann. § 442.053 (2026).

Text

Sec. 442.053. REQUIREMENTS FOR DONATED PRESCRIPTION DRUGS.

(a)A donated prescription drug may be accepted or dispensed under this chapter only if the drug is in its original, unopened, sealed, and tamper-evident bottle, container, or unit-dose packaging. A drug packaged in single unit doses may be accepted and dispensed if the outside packaging is opened but the single unit-dose packaging is unopened.

(b)A donated prescription drug may not be accepted or dispensed under this chapter if:

(1)the drug is a controlled substance;

(2)the drug is adulterated or misbranded;

(3)the drug is not stored in compliance with the drug's product label; or

(4)the United States Food and Drug Administration requires the drug to have a risk evaluation or mitigation strategy.

(c)A participating provider

Free access — add to your briefcase to read the full text and ask questions with AI

Sec. 442.053. REQUIREMENTS FOR DONATED PRESCRIPTION DRUGS. (a) A donated prescription drug may be accepted or dispensed under this chapter only if the drug is in its original, unopened, sealed, and tamper-evident bottle, container, or unit-dose packaging. A drug packaged in single unit doses may be accepted and dispensed if the outside packaging is opened but the single unit-dose packaging is unopened.
(b) A donated prescription drug may not be accepted or dispensed under this chapter if:
(1) the drug is a controlled substance;
(2) the drug is adulterated or misbranded;
(3) the drug is not stored in compliance with the drug's product label; or
(4) the United States Food and Drug Administration requires the drug to have a risk evaluation or mitigation strategy.
(c) A participating provider shall comply with all applicable provisions of state and federal law relating to the inspection, storage, labeling, and dispensing of prescription drugs.

Legislative History

Added by Acts 2017, 85th Leg., R.S., Ch. 485 (H.B. 2561 ), Sec. 7(a), eff. September 1, 2017. Amended by: Acts 2023, 88th Leg., R.S., Ch. 758 (H.B. 4166 ), Sec. 1, eff. September 1, 2023.